Community Practice

Latest News


CME Content


The Food and Drug Administration's "Medication Guide" program, set up nine years ago as a major avenue of informing patients about risks or special issues with certain drugs, has a host of problems, according to pharmacists and other witnesses at a recent hearing.

Most Americans probably never gave tuberculosis (TB) a passing thought until a case of extensively drug-resistant TB (XDR TB) recently made national headlines. An American with XDR TB traveled from the United States to Europe and back in May, potentially exposing hundreds of fellow travelers to the disease. Since then, national public concern about TB has ballooned.

Adults and children six years of age and older who suffer with seasonal and perennial allergic rhinitis will now have another option for relief of their symptoms. Levocetirizine (Xyzal) from UCB Inc. and Sanofi-Aventis has received regulatory approval from the FDA.

NABP announced that Patient Care Infusion dba Arizona Home Care has received accreditation through the association's durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) accreditation program.

A Government Accountability Office report found enrollment delays and excessive payments for beneficiaries who are eligible for both Medicare and Medicaid.

The National Coalition of Pharmaceutical Distributors (NCPD) has come out in support of a lawsuit aimed at preventing the implementation of new pedigree requirements for the Prescription Drug Marketing Act (PDMA).

A federal judge ruled that AstraZeneca, a subsidiary of Schering-Plough, and Bristol-Myers Squibb are guilty of reporting false average wholesale prices for a number of prescription drugs in violation of a Massachusetts consumer protection law.

The Academy of Managed Care Pharmacy and ASHP have approved a new standard for managed care pharmacy residencies that aims to improve training for pharmacists as they prepare for this specialized area of practice. T

The new labeling requirements came about after the USP reviewed numerous case reports suggesting a potential link between ingestion of products containing green tea extracts and black cohosh and liver damage.

The new service, called HybridRx, is an extension of the company's onsite healthcare solution, Hybrid Health, which offers a comprehensive range of healthcare services for client employees, retirees, and their dependents.